Anterior segment dysgenesis 6
MONDO:0015016Also known as: ASGD6, anterior segment dysgenesis 6, anterior segment dysgenesis 6, multiple subtypes, anterior segment dysgenesis type 6
10 clinical trials for this condition and its sub-types, 1 tagged with Anterior segment dysgenesis 6 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Glaucoma patients: could this supplement save your sight?
Disease control Recruiting nowThis study tests whether a daily supplement called BrudyGlauco (containing DHA and citicoline) can help protect eyesight in people with glaucoma. About 108 participants will take either the supplement or a placebo for 12 months. The goal is to see if it slows vision loss and impr…
Sponsor: Institut Catala de Retina • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can better Follow-Up schedules save sight in glaucoma?
Knowledge-focused Recruiting nowResearchers at a German university eye hospital collect and anonymize data from about 10,000 people with glaucoma, ocular hypertension, or suspected glaucoma. They study how often patients should return for check-ups and which treatments best lower eye pressure for each person. T…
Sponsor: Technische Universität Dresden • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a tiny eye surgery keep glaucoma in check for years?
Knowledge-focused Recruiting nowThis study looks at how well a minimally invasive glaucoma surgery called ab-interno trabeculotomy (AIT) holds up over the long term. Researchers will review the medical records of 200 glaucoma patients who had the surgery between 2019 and 2021 and invite them for a single follow…
Sponsor: Wuerzburg University Hospital • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
800 kids with rare eye conditions to be tracked for 10 years
Knowledge-focused Recruiting nowThis study follows 800 children born with eye malformations like microphthalmia, anophthalmia, aniridia, or anterior segment defects. Researchers will track their vision, brain development, and overall health for up to 10 years to better predict outcomes. No new treatments are be…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC